Skip to content
Twitter Facebook-f Youtube Instagram Linkedin
NETs Info
Donate
Close Menu
  • Who We Are
    • About Us
    • Our People
    • Our Board
    • Our Ambassadors
    • Consumer Advisory Group
    • International Advisory Panel
    • Governance & Policy
  • Neuroendocrine Cancers
    • What are Neuroendocrine Cancers?
    • Patient Resources
    • Pheos and Paras
    • NET Library
  • Optimal Care Pathway
    • For Patients
    • For Health Professionals
  • I Am a Patient
    • Patient Support
    • Patient Resources
    • NET Nurse
    • Patient Stories
    • Australian NET Specialists
    • Current Clinical Trials
  • I am a HCP
    • Professional Learning
    • HCP – Patient Referral to NET Nurse
    • Current Clinical Trials
    • NET Library
    • HCP Newsletter & Signup
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order booklets and other resources
  • Get Involved
    • Advocate for us
    • Share your story
    • Donate
    • Fundraise
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Workplace Giving
    • Volunteer
  • What’s On
    • News
    • Newsletter & Signup
    • INCA Newsletter archive
    • Events
  • Shop
  • Contact Us
Donate
  • Who We Are
    • About Us
    • Our People
    • Our Board
    • Our Ambassadors
    • Consumer Advisory Group
    • International Advisory Panel
    • Governance & Policy
  • Neuroendocrine Cancers
    • What are Neuroendocrine Cancers?
    • Patient Resources
    • Pheos and Paras
    • NET Library
  • Optimal Care Pathway
    • For Patients
    • For Health Professionals
  • I Am a Patient
    • Patient Support
    • Patient Resources
    • NET Nurse
    • Patient Stories
    • Australian NET Specialists
    • Current Clinical Trials
  • I am a HCP
    • Professional Learning
    • HCP – Patient Referral to NET Nurse
    • Current Clinical Trials
    • NET Library
    • HCP Newsletter & Signup
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order booklets and other resources
  • Get Involved
    • Advocate for us
    • Share your story
    • Donate
    • Fundraise
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Workplace Giving
    • Volunteer
  • What’s On
    • News
    • Newsletter & Signup
    • INCA Newsletter archive
    • Events
  • Shop
  • Contact Us

Home » Advocacy » Let’s BE FAIR with government cancer funding

Let’s BE FAIR with government cancer funding

  • April 28, 2019


The Unicorn Foundation is leveraging this years’ upcoming Federal election to shine a light on the often unfair and imbalanced distribution of funding to cancer organisations, asking the government of the day, for equitable support for all cancer types. 

The NET Nurse advocacy campaign is vying for government support to fund specialist neuroendocrine cancer (NET) nurses to service the 10,000+ men and women across Australia who are living with this form of cancer.

Since 2014 when the Unicorn Foundation launched their first NET Nurse trial, they have been lobbying (pleading) for Federal funding of a specialist NET nurse (or Cancer Care Coordinator). Thanks to an initial one year grant from Tour de Cure the service started in 2014, and has since been funded through another one year grant from Tour de Cure, and patient and community fundraising.

Whilst specific federal funding has been denied in the past, the Unicorn Foundation has seen exponential growth in patient numbers and is now at capacity. Financial aid is desperately needed to expand this vital service.

The funding would be consistent with the financial assistance that has already been provided by the Australian government to support other cancer organisations such as:

·        $22 million provided to the McGrath Foundation Breast Care Nurses (every four years)

·        $12 million provided to Prostate Cancer Nurses

·        $1.6 million provided to Ovarian Cancer Australia

Whilst we support these organisations (we collaborate closely), and their equal need for funding, we are perplexed by the lack of consistency in funding especially when you look at needs-based funding. NET patients live with high burden because of their incurable disease and lack of support services, and therefore should be placed as a priority.


Source: Australian Institute of Health and Welfare – AIHW

The Unicorn Foundation is requesting that the Australian Government allocate $1.35 million of their total healthcare budget to finance the expansion of a Neuroendocrine Specialist Cancer Care Support Service.  This funding will cover the costs of five Specialist NET Cancer Care Coordinators over a three-year period and provide a greater level of care to the thousands of NET cancer patients living throughout Australia.

For a full breakdown of the proposed funding grant please contact Simone Leyden at simone.leyden@neuroendocrine.org.au, or get behind the campaign by telling your story and sending the attached letter to your local member to lobby on your behalf. Make sure to tell your story.

Click here to find your local minister 

Letters should also be sent to:

Minister Greg Hunt, Federal Health Minister – Greg.Hunt.MP@aph.gov.au

Prime Minister Scott Morrison – scott.morrison.mp@aph.gov.au

Shadow Health Minister Catherine King –  catherine.king.mp@aph.gov.au

Opposition Leader Bill Shorten – bill.shorten.mp@aph.gov.au

To push the message home here is just one story of many, from a patient that came through our NET nurse service:

NET Nurse Kate Wakelin tells the story of this NET patient from WA….

“Just one of many stories that comes through the helpline was from a lady in remote WA. She found a breast lump in the shower, and went to her GP, who sent her off for a mammogram, where they found she had a suspicious looking lump, and was recommended to have surgery. It was at this stage she was introduced to her breast care nurse, who met with her, and explained everything she needed to know leading into the surgery, as well as providing much needed emotional support. She provided her with written information, and a contact number in case she had concerns at any stage. She was told that breast cancer is usually found early, and that treatment would most likely be curative – perhaps she would only need the surgery, or possibly some follow-up chemotherapy/radiotherapy.

The surgery proceeded smoothly – our patient was visited in hospital by her breast care nurse, who checked that she understood her post-operative care, and made sure she had all the details of her post-op visit. She was linked in with her local breast cancer support group, as well as a breast cancer exercise group, both of which she started to attend soon after getting home.

When she attended the clinic for her 6 week post-operative check, she was shocked to find out that she had been diagnosed with aneuroendocrine cancer. Neither the surgeon or the breast care nurse had ever seen one of these tumours before. Our patient found out that this tumour had most likely spread from another part of her body, and as a metastatic cancer,would not be considered curable. 

My patient told me that in an instant, all of the beautiful, supportive breast cancer services – the breast care nurse, the support group,the exercise class were no longer available to her. She told me she was “dropped like a hot coal”. Not only had she found out she had a terminal illness, but all of a sudden she had no support at all, and needed to navigate the post-operative period (including complications which would normally be managed by the breast care nurse), on her own.
She found the Unicorn Foundation by chance, having resorted to Google, in order to find out more about this mysterious neuroendocrine cancer. Although I was able to speak with this lady over the phone, and send her some printed information, I didn’t get to meet her until several years after her diagnosis, when I was able to travel to Perth for a conference, and she drove the four hours to see me.”

A heartbreaking yet all too common story from NET patients around the country.

Thank you everyone, we hope that we get the message out there to “Be Fair”.

 

 

Share this post

Subscribe to our eNews

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Recent posts

Michael Doyle Live Wake Fundraiser

February 4, 2023

Optimal Care Pathway now available for NETs

January 31, 2023

World Cancer Day 2023

January 10, 2023

Support Groups Christmas Gatherings

December 20, 2022
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
PrevPreviousENETs Overview
NextMultidisciplinary approach highlights Nurses role in NETs careNext

Related Posts

Michael Doyle Live Wake Fundraiser

On Saturday February 4th our Consumer Advisory Group member for Western Australia, Michael Doyle not only celebrated his 65th birthday but also held a “live

World Cancer Day 2023

World Cancer Day: a leading international awareness day to “Close the Care Gap” World Cancer Day held on 4 February every year is the global

NeuroEndocrine Cancer Australia & Norman Family Trust Partnership

NeuroEndocrine Cancer Australia are delighted to announce a new donor partnership. The Norman Family Bequest are funding a NET Nurse Educator in memory of Will

NeuroEndocrine Cancer Australia partners with Gathered Here to provide the NET community with free online Wills

NeuroEndocrine Cancer Australia have partnered with Gathered Here, Australia’s most-trusted end-of-life services site, to offer our supporters a free online will. We are constantly looking

View All

Make a difference

How much do you wish to donate?
$50
$100
$250
$500
$1000
Other
NeuroEndocrine Cancer Australia logo white
Twitter Facebook-f Youtube Instagram Linkedin

All donations are tax deductible.
Registered Charity CFN 202607

Who We Are

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Neuroendocrine Cancers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

For Patients

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise

© 2020 NeuroEndocrine Cancer Australia

  • Website by Five Creative